Meeting
2020 Gastrointestinal Cancers Symposium
Real-world costs of cetuximab + chemotherapy administered every two weeks versus weekly for treatment of metastatic colorectal cancer.
Authors
Chris Pescott
Global Evidence and Value Department, Merck KGaA, Darmstadt, Germany
Chris Pescott , Michael Batech , Emmanuelle Boutmy , Philippe Ronga , Francois-Xavier Lamy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 22)
Abstract #
22
Poster Bd #
A16
Abstract Disclosures